The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the P.E.Analytics IPO is up to ₹30.01 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of P.E.Analytics IPO is ₹114.00 per share.
Evoq Remedies IPO opens on Mar 17, 2022, while P.E.Analytics IPO opens on Mar 22, 2022. The closing date of Evoq Remedies IPO and P.E.Analytics IPO is Mar 22, 2022, and Mar 25, 2022, respectively.
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in P.E.Analytics IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and 5,26,800 shares in P.E.Analytics IPO.
